Skip to main content

Claritev

Closed (deSPAC)

Health Care · healthcare technology, data and insights

What it is
A private company in health care preparing to list via a SPAC merger. Full profile in progress.
What it’s doing now
Merging with Butler Acquisition Corp (CCXX) — closed (despac).
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.
Profile in progress — we only publish what we can verify in filings, and for this company that work isn’t finished. Identity and deal facts above are current; business detail, financials and peers will appear as the filings are parsed.

What the company says about itself

Web research — not audited

Claritev is a healthcare technology company that provides AI-enabled solutions aimed at improving transparency, quality, and affordability across the healthcare ecosystem. With over 45 years of healthcare data processing experience, the company offers claims intelligence, data and analytics, network management, and payment and revenue integrity solutions to help organizations reduce costs and make better decisions.

Markets:
Healthcare | Health Insurance | Health Plans | Brokers | Employers | Government | Hospitals & Health Systems
Products:
Claims Intelligence Solutions | Data & Analytics Solutions | Network Solutions | Payment & Revenue Integrity Solutions | Professional Services | Data iSight | Vistara | Pro Pricer | No Surprises Act (NSA) Services | State Surprise Bill Services | Financial Negotiations | BenInsights | Medical Claims Integration | Ceres | PlanOptix | CompleteVue | PHCS Network | Complementary Networks | Government Networks | MultiPlan Complementary Network | ValuePoint
Customers:
New River Health Association Breathing Center | Elizabeth Dole Foundation | Insurance Office of America
What our web check found

[WEB-INTEL 2026-08-26] 11 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Churchill Capital Corp (CCC), a special purpose acquisition company that completed a $690 million initial public offering in September 2018 and merged in May" [https://www.renaissancecapital.com/Profile/CTEV/Claritev/IPO] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Claritev completed a $77.25 million follow-on equity offering of 1.5 million shares of Class A common stock at $51.50 per share, priced at a $2" [https://finance.yahoo.com/news/recent-developments-rewriting-claritev-investment-180710579.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "MultiPlan and Churchill Capital Corp III announced the closing of their business combination, creating a publicly traded company over $3.6" [https://www.claritev.com/insights/multiplan-and-churchill-capital-corp-iii-announce-closing-of-business-combination/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Confirms the anticipated closing date for the MultiPlan business combination will be October 8, 2020" [https://investors.claritev.com/static-files/2724267f-45e5-4890-8074-879127a0da8e] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Churchill III and MultiPlan also announced that their pending business combination is scheduled to occur on October 8, 2020, the day immediately" [https://investors.claritev.com/static-files/037091e7-81a3-4510-8ee1-7e30cb4fe137] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Revenues of $244.7 million for Q1 2026, an increase of 5.8%, compared to revenues of $231.3 million for Q1 2025. Net loss of $73.6 million for Q1 2026," [https://investors.claritev.com/news-releases/news-release-details/claritev-corporation-reports-first-quarter-2026-results] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Revenues of $257.5 million grew 6.6%" [https://investors.claritev.com/news-events/news-releases] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "As of December 31, 2024, the Company's cash and cash equivalents and short-term investments totaled $11.6 million, and there was $15.1 million" [https://www.facebook.com/claritev/posts/today-claritev-announced-a-strong-to-start-to-2026-our-first-quarter-2026-result/1584458113680051/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "With a market capitalization of $293.15 million, the company is positioned as a small-cap stock with significant growth potential." [https://www.directorstalkinterviews.com/claritev-corporation-ctev-stock-analysis-potential-152-upside-captivates-investors/4121243307] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "$71.8M This year, Claritev Corporation is projected to spend $71.8M on IT, according to Aberdeen." [https://www.crunchbase.com/organization/multiplan] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "over $1B revenue and $7.2B funding" [https://leadiq.com/c/claritev/5a1d87902400002400618680]

Source: https://www.claritev.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Claritev is merging with Butler Acquisition Corp (CCXX) currently marked Closed (deSPAC).

Headline equity value
PIPE≈ $1.3B · unsourced

Structure per SEC accession(s) 0001104659-20-106245. How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Claritev going public?

Claritev has an approved merger with the SPAC Butler Acquisition Corp (CCXX). Deal status: Closed (deSPAC).

Does Claritev have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals